O'Laughlin R - Search Results

1

Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.

Woodle ES, Xu D, Zivin RA, Auger J, Charette J, O'Laughlin R, Peace D, Jollife LK, Haverty T, Bluestone JA, Thistlethwaite JR Jr. Woodle ES, et al. Transplantation. 1999 Sep 15;68(5):608-16. doi: 10.1097/00007890-199909150-00003. Transplantation. 1999. PMID: 10507477 Clinical Trial.

2

OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.

Woodle ES, Bruce DS, Josephson M, Cronin D, Newell KA, Millis JM, Piper JB, O'Laughlin R, Thistlethwaite JR Jr. Woodle ES, et al. Clin Transplant. 1996 Aug;10(4):389-95. Clin Transplant. 1996. PMID: 8884115

3

Successful use of tacrolimus for initial rejection episodes after liver transplantation.

Millis JM, Cronin DC, Newell KA, Bruce DS, Woodle ES, Grewal HP, Loss GE, Lissoos T, Conjeevaram H, Schiano T, O'Laughlin R, Charette J, McNaughton M, Baker AL, Thistlethwaite JR Jr. Millis JM, et al. Transplant Proc. 1998 Jun;30(4):1407-8. doi: 10.1016/s0041-1345(98)00292-9. Transplant Proc. 1998. PMID: 9636569 Clinical Trial. No abstract available.

4

Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia.

Gradishar WJ, Le Beau MM, O'Laughlin R, Vardiman JW, Larson RA. Gradishar WJ, et al. Blood. 1992 Nov 15;80(10):2463-70. Blood. 1992. PMID: 1421369 Free article. Clinical Trial.

5

A patterned human neural tube model using microfluidic gradients.

Xue X, Kim YS, Ponce-Arias AI, O'Laughlin R, Yan RZ, Kobayashi N, Tshuva RY, Tsai YH, Sun S, Zheng Y, Liu Y, Wong FCK, Surani A, Spence JR, Song H, Ming GL, Reiner O, Fu J. Xue X, et al. Among authors: o laughlin r. Nature. 2024 Apr;628(8007):391-399. doi: 10.1038/s41586-024-07204-7. Epub 2024 Feb 26. Nature. 2024. PMID: 38408487

6

A Standardized Set of MoClo-Compatible Inducible Promoter Systems for Tunable Gene Expression in Yeast.

O'Laughlin R, Tran Q, Lezia A, Ngamkanjanarat W, Emmanuele P, Hao N, Hasty J. O'Laughlin R, et al. ACS Synth Biol. 2024 Jan 19;13(1):85-102. doi: 10.1021/acssynbio.3c00184. Epub 2023 Dec 11. ACS Synth Biol. 2024. PMID: 38079574

7

A Microfluidic Platform for Screening Gene Expression Dynamics across Yeast Strain Libraries.

Stasiowski E, O'Laughlin R, Holness S, Csicsery N, Hasty J, Hao N. Stasiowski E, et al. Among authors: o laughlin r. Bio Protoc. 2023 Nov 20;13(22):e4883. doi: 10.21769/BioProtoc.4883. eCollection 2023 Nov 20. Bio Protoc. 2023. PMID: 38023791 Free PMC article.

8

Fabrication of Microfluidic Devices for Continuously Monitoring Yeast Aging.

O'Laughlin R, Forrest E, Hasty J, Hao N. O'Laughlin R, et al. Bio Protoc. 2023 Aug 5;13(15):e4782. doi: 10.21769/BioProtoc.4782. eCollection 2023 Aug 5. Bio Protoc. 2023. PMID: 37575396 Free PMC article.

9

Age-dependent aggregation of ribosomal RNA-binding proteins links deterioration in chromatin stability with challenges to proteostasis.

Paxman J, Zhou Z, O'Laughlin R, Liu Y, Li Y, Tian W, Su H, Jiang Y, Holness SE, Stasiowski E, Tsimring LS, Pillus L, Hasty J, Hao N. Paxman J, et al. Among authors: o laughlin r. Elife. 2022 Oct 4;11:e75978. doi: 10.7554/eLife.75978. Elife. 2022. PMID: 36194205 Free PMC article.

10

Patterning of brain organoids derived from human pluripotent stem cells.

Zhang Z, O'Laughlin R, Song H, Ming GL. Zhang Z, et al. Among authors: o laughlin r. Curr Opin Neurobiol. 2022 Jun;74:102536. doi: 10.1016/j.conb.2022.102536. Epub 2022 Apr 8. Curr Opin Neurobiol. 2022. PMID: 35405627 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page